معرفی
Dr. Erik M. Shapiro is a Professor at Michigan State University, serving as faculty in both the Neuroscience Program and Genetics & Genome Sciences Program. He directs the Molecular and Cellular Imaging Laboratory (MCIL), where his research sits at the interface of neuroscience, chemistry, and biomedical engineering. His laboratory develops specific and sensitive molecular imaging approaches to study the brain in both naïve and diseased animals, with significant contributions to nanotechnology, stem cell biology, and medical imaging. Biomedical goals include early detection of neurodegenerative diseases, targeted detection and therapy of cancer, and imaging the manipulation of neurogenesis, primarily performed in rodent models with clinical translation as a key objective.
Dr. Shapiro's research interests center on molecular and cellular imaging techniques with particular emphasis on neuroscience applications. His laboratory develops innovative imaging methodologies to investigate brain function in both healthy and disease states, bridging fundamental neuroscience with clinical applications. Current research areas include nanotechnology for biomedical imaging, stem cell tracking methodologies, and medical imaging techniques for early detection of neurodegenerative diseases and targeted cancer therapies. His work consistently demonstrates interdisciplinary approaches that integrate chemistry, engineering, and biology to solve complex biomedical problems, with a strong focus on translational research that moves discoveries from bench to bedside.
Analysis of Dr. Shapiro's recent publications (2023-2025) reveals a strong research trajectory focused on advanced imaging technologies, particularly in MRI and CT applications. His work shows increasing emphasis on radiopaque biomaterials for nerve repair, nanoparticle-based contrast agents, and in vivo monitoring of device degradation. Key trends include the development of tantalum oxide nanoparticles as X-ray contrast agents, MRI-based cell tracking techniques using OATP transporters, and intraductal ablative procedures for breast cancer prevention. His publications consistently demonstrate innovation in imaging technology development with direct biomedical applications, particularly in neural repair and cancer research, reflecting his laboratory's mission to develop and apply molecular imaging approaches for significant clinical problems.
Dr. Shapiro directs the Molecular and Cellular Imaging Laboratory (MCIL) at Michigan State University, where his team conducts cutting-edge interdisciplinary research. The laboratory's work spans multiple domains including nanotechnology development for biomedical imaging, stem cell tracking methodologies, and medical imaging techniques for early detection of neurodegenerative diseases. Current projects include developing radiopaque implantable biomaterials for nerve repair, incorporating tantalum oxide nanoparticles into polymeric biomedical devices, and investigating material degradation effects on regenerating Schwann cells. The MCIL emphasizes not only laboratory work but also comprehensive student training in conference presentations, grant and manuscript preparation, and professional interactions, preparing students to not only DO science but to BE scientists.
